⌘K
Loading ticker…
As of 2026-08-24, Evolent Health, Inc Class A Common Stock (EVH) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 55. The current market Stance is 47.8 (Neutral). Sector: Industrials, ranked 6 of 11. Average daily range 8.9%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
EVH is held by 16 ETFs as of May 2026. Top owner: FNDA at 0.03% weight, $3M notional. Top 3 carry $7M.
Held by 36 ETFs · $38M across latest filings · largest weight 0.18% (VFVA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FNDA | 0.03% | $3M | +0.01 pp |
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VFVA | 0.18% | $2M | new |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $341K |
| new |
| VTWV | 0.02% | $236K | — |
| VTWG | 0.01% | $136K | — |
| FNDB | 0.00% | $37K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $37K | — |
Showing 10 of 16 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EVH Jan avg: -5.77% median: -9.04% win: 25% σ: 14.66% n: 4 2022-04-12 → 2026-07-31 | EVH Feb avg: 2.81% median: 4.95% win: 75% σ: 12.57% n: 4 2022-04-12 → 2026-07-31 | EVH Mar avg: -8.78% median: -5.31% win: 25% σ: 15.00% n: 4 2022-04-12 → 2026-07-31 | EVH Apr avg: 12.10% median: 4.12% win: 60% σ: 31.03% n: 5 2022-04-12 → 2026-07-31 | EVH May avg: -12.09% median: -19.97% win: 40% σ: 14.63% n: 5 2022-04-12 → 2026-07-31 | EVH Jun avg: 18.35% median: 9.17% win: 80% σ: 25.06% n: 5 2022-04-12 → 2026-07-31 | EVH Jul avg: -4.16% median: 0.30% win: 60% σ: 24.87% n: 5 2022-04-12 → 2026-07-31 | EVH Aug avg: 6.30% median: 2.07% win: 50% σ: 22.80% n: 4 2022-04-12 → 2026-07-31 (current) | EVH Sep avg: -4.85% median: -6.90% win: 25% σ: 8.99% n: 4 2022-04-12 → 2026-07-31 | EVH Oct avg: -15.09% median: -14.45% win: 0% σ: 5.12% n: 4 2022-04-12 → 2026-07-31 | EVH Nov avg: -19.35% median: -23.26% win: 25% σ: 26.77% n: 4 2022-04-12 → 2026-07-31 | EVH Dec avg: -0.34% median: -3.61% win: 25% σ: 13.53% n: 4 2022-04-12 → 2026-07-31 |